Publications

Want to be in the know about the latest advances in diabetes research? Need more information on how to live well with T1D? Connect with us on social networking sites, subscribe to our emails, and check out our print and online materials.



Countdown

  • Boost JDRF research progress at Walgreens and Duane Reade

    Get your flu shot at your community Walgreens or Duane Reade and JDRF will receive money for T1D research From September 1 to November 30, Walgreens will donate $1 to JDRF per flu shot to our supporters — up to a total of $100,000! Download and bring in this JDRF promotional flyer on your visit. […]

    Read More

  • Research Teamwork is Key to Curing Type 1 Diabetes

    JDRF takes center stage at Capitol Hill briefing on accelerating biomedical research progress Richard A. Insel, M.D., JDRF’s Chief Scientific Officer, joined other research leaders at a Congressional briefing on, “How the Research-by-Consortia Model Will Lead to Faster Cures” held recently in Washington D.C. The briefing brought together biomedical leaders from foundations, industry, government, and […]

    Read More

  • JDRF Partner ViaCyte to Immediately Initiate Type 1 Diabetes Clinical Trial

    JDRF’s partner ViaCyte recently announced the U.S. Food and Drug Administration (FDA) is allowing them to move forward with a clinical trial of its innovative type 1 diabetes (T1D) encapsulated cell replacement therapy called VC-01™ product candidate. The company plans to immediately initiate the first ever clinical evaluation of a stem cell-derived islet replacement therapy […]

    Read More

  • Oxygen – A Key Ingredient of Life

    JDRF partners with Beta-O2 Technologies to develop a novel implantable encapsulation device for type 1 diabetes The dream for everyone with type 1 diabetes (T1D) is to permanently restore their body’s lost ability to produce insulin. This defines a cure for T1D and remains a top priority for JDRF. As we work towards this longer-term […]

    Read More

  • Rebalancing the Immune System

    Novel therapy to increase beneficial immune cells shows promise in pilot type 1 diabetes clinical study Type 1 diabetes (T1D) is caused when a person’s immune system mistakenly destroys their insulin-producing beta cells. How and why this misguided attack begins remains a mystery, but JDRF research has helped shed light on the disease process, opening […]

    Read More